Eliminylation: a post-translational modification catalyzed by phosphothreonine lyases

Pawson, 2005, Protein phosphorylation in signalling – 50 years and counting, Trends Biochem. Sci., 30, 286, 10.1016/j.tibs.2005.04.013 Mattoo, 2007, Interactions of bacterial effector proteins with host proteins, Curr. Opin. Immunol., 19, 392, 10.1016/j.coi.2007.06.005 Mukherjee, 2007, A newly discovered post-translational modification–the acetylation of serine and threonine residues, Trends Biochem. Sci., 32, 210, 10.1016/j.tibs.2007.03.007 Francis, 2002, Regulation of type III secretion systems, Curr. Opin. Microbiol., 5, 166, 10.1016/S1369-5274(02)00301-6 Gulig, 1990, Genetic and DNA sequence analysis of the Salmonella typhimurium virulence plasmid gene encoding the 28,000-molecular-weight protein, Infect. Immun., 58, 2651, 10.1128/IAI.58.8.2651-2658.1990 Matsui, 2001, Virulence plasmid-borne spvB and spvC genes can replace the 90-kilobase plasmid in conferring virulence to Salmonella enterica serovar Typhimurium in subcutaneously inoculated mice, J. Bacteriol., 183, 4652, 10.1128/JB.183.15.4652-4658.2001 Mazurkiewicz, 2008, SpvC is a Salmonella effector with phosphothreonine lyase activity on host mitogen-activated protein kinases, Mol. Microbiol., 67, 1371, 10.1111/j.1365-2958.2008.06134.x Arbibe, 2007, An injected bacterial effector targets chromatin access for transcription factor NF-κB to alter transcription of host genes involved in immune responses, Nat. Immunol., 8, 47, 10.1038/ni1423 Li, 2007, The phosphothreonine lyase activity of a bacterial type III effector family, Science, 315, 1000, 10.1126/science.1138960 Zhang, 2007, A Pseudomonas syringae effector inactivates MAPKs to suppress PAMP-induced immunity in plants, Cell Host Microbe, 1, 175, 10.1016/j.chom.2007.03.006 Zhu, 2007, Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase, Mol. Cell, 28, 899, 10.1016/j.molcel.2007.11.011 Chen, 2008, Structural basis for the catalytic mechanism of phosphothreonine lyase, Nat. Struct. Mol. Biol., 15, 101, 10.1038/nsmb1329 Kim, 2008, OspF directly attenuates the activity of extracellular signal-regulated kinase during invasion by Shigella flexneri in human dendritic cells, Mol. Immunol., 45, 3295, 10.1016/j.molimm.2008.02.013 Kramer, 2007, Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation, PLoS Pathog., 3, e21, 10.1371/journal.ppat.0030021 Tena, 2001, Plant mitogen-activated protein kinase signaling cascades, Curr. Opin. Plant Biol., 4, 392, 10.1016/S1369-5266(00)00191-6 Li, 2005, Flagellin induces innate immunity in nonhost interactions that is suppressed by Pseudomonas syringae effectors, Proc. Natl. Acad. Sci. U. S. A., 102, 12990, 10.1073/pnas.0502425102 He, 2006, Specific bacterial suppressors of MAMP signaling upstream of MAPKKK in Arabidopsis innate immunity, Cell, 125, 563, 10.1016/j.cell.2006.02.047 Zurawski, 2006, OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence, Infect. Immun., 74, 5964, 10.1128/IAI.00594-06 Humphrey, 1997, Chemical synthesis of natural product peptides: coupling methods for the incorporation of noncoded amino acids into peptides, Chem. Rev., 97, 2243, 10.1021/cr950005s Bhatnagar, 1995, The role of dehydro-alanine in the design of peptides, Biosystems, 34, 143, 10.1016/0303-2647(94)01445-D Chatterjee, 2005, Lacticin 481 synthetase phosphorylates its substrate during lantibiotic production, J. Am. Chem. Soc., 127, 15332, 10.1021/ja0543043 Siegers, 1996, Biosynthesis of lantibiotic nisin. Posttranslational modification of its prepeptide occurs at a multimeric membrane-associated lanthionine synthetase complex, J. Biol. Chem., 271, 12294, 10.1074/jbc.271.21.12294 Ingram, 1969, Synthesis of the antibiotic nisin: formation of lanthionine and β-methyl-lanthionine, Biochim. Biophys. Acta, 184, 216, 10.1016/0304-4165(69)90121-4 Li, 2006, Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis, Science, 311, 1464, 10.1126/science.1121422 Mayer, 2001, Characterization of rat LANCL1, a novel member of the lanthionine synthetase C-like protein family, highly expressed in testis and brain, Gene, 269, 73, 10.1016/S0378-1119(01)00463-2 Helfrich, 2007, Structure-function relationships of the lanthionine cyclase SpaC involved in biosynthesis of the Bacillus subtilis peptide antibiotic subtilin, Biochemistry, 46, 3224, 10.1021/bi062124f Xie, 2004, Post-translational modifications during lantibiotic biosynthesis, Curr. Opin. Chem. Biol., 8, 498, 10.1016/j.cbpa.2004.08.005 Friedman, 1999, Lysinoalanine in food and in antimicrobial proteins, Adv. Exp. Med. Biol., 459, 145, 10.1007/978-1-4615-4853-9_10 Blaesse, 2000, Crystal structure of the peptidyl-cysteine decarboxylase EpiD complexed with a pentapeptide substrate, EMBO J., 19, 6299, 10.1093/emboj/19.23.6299 Linetsky, 2004, Dehydroalanine crosslinks in human lens, Exp. Eye Res., 79, 499, 10.1016/j.exer.2004.06.026 Srivastava, 2004, Characterization of covalent multimers of crystallins in aging human lenses, J. Biol. Chem., 279, 10901, 10.1074/jbc.M308884200 Speth, 2007, Pathogen virulence factors as molecular probes of basic plant cellular functions, Curr. Opin. Plant Biol., 10, 580, 10.1016/j.pbi.2007.08.003 Roberts, 2007, Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer, Oncogene, 26, 3291, 10.1038/sj.onc.1210422 Murphy, 2006, MAPK signal specificity: the right place at the right time, Trends Biochem. Sci., 31, 268, 10.1016/j.tibs.2006.03.009 Solit, 2006, BRAF mutation predicts sensitivity to MEK inhibition, Nature, 439, 358, 10.1038/nature04304 Hall-Jackson, 1999, Paradoxical activation of Raf by a novel Raf inhibitor, Chem. Biol., 6, 559, 10.1016/S1074-5521(99)80088-X Hall-Jackson, 1999, Effect of SB 203580 on the activity of c-Raf in vitro and in vivo, Oncogene, 18, 2047, 10.1038/sj.onc.1202603 Verma, 2005, Gene therapy: twenty-first century medicine, Annu. Rev. Biochem., 74, 711, 10.1146/annurev.biochem.74.050304.091637 Ryan, 2006, Use of bacteria in anti-cancer therapies, Bioessays, 28, 84, 10.1002/bies.20336 Westphal, 2008, Containment of tumor-colonizing bacteria by host neutrophils, Cancer Res., 68, 2952, 10.1158/0008-5472.CAN-07-2984 Trosky, 2007, VopA inhibits ATP binding by acetylating the catalytic loop of MAPK kinases, J. Biol. Chem., 282, 34299, 10.1074/jbc.M706970200 Hotson, 2003, Xanthomonas type III effector XopD targets SUMO-conjugated proteins in planta, Mol. Microbiol., 50, 377, 10.1046/j.1365-2958.2003.03730.x Rohde, 2007, Type III secretion effectors of the IpaH family are E3 ubiquitin ligases, Cell Host Microbe, 1, 77, 10.1016/j.chom.2007.02.002 Rytkonen, 2007, SseL, a Salmonella deubiquitinase required for macrophage killing and virulence, Proc. Natl. Acad. Sci. U. S. A., 104, 3502, 10.1073/pnas.0610095104 Kim, 2005, The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes, Proc. Natl. Acad. Sci. U. S. A., 102, 14046, 10.1073/pnas.0504466102 Espinosa, 2003, The Pseudomonas syringae type III-secreted protein HopPtoD2 possesses protein tyrosine phosphatase activity and suppresses programmed cell death in plants, Mol. Microbiol., 49, 377, 10.1046/j.1365-2958.2003.03588.x Lin, 2003, SptP, a Salmonella typhimurium type III-secreted protein, inhibits the mitogen-activated protein kinase pathway by inhibiting Raf activation, Cell. Microbiol., 5, 267, 10.1046/j.1462-5822.2003.t01-1-00274.x Poh, 2008, SteC is a Salmonella kinase required for SPI-2-dependent F-actin remodelling, Cell. Microbiol., 10, 20 Navarro, 2007, Identification of a molecular target for the Yersinia protein kinase A, Mol. Cell, 26, 465, 10.1016/j.molcel.2007.04.025 Persson, 1997, The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions, EMBO J., 16, 2307, 10.1093/emboj/16.9.2307 Canagarajah, 1997, Activation mechanism of the MAP kinase ERK2 by dual phosphorylation, Cell, 90, 859, 10.1016/S0092-8674(00)80351-7 Jansonius, 1998, Structure, evolution and action of vitamin B6-dependent enzymes, Curr. Opin. Struct. Biol., 8, 759, 10.1016/S0959-440X(98)80096-1